| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Repligen Corporation (RGEN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. RGEN is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 99.0K | $12.53M | - | |
| Dir | 91.8K | $11.62M | - | |
| CEO | 54.2K | $6.87M | - | |
| VP | 20.1K | $2.54M | - | |
| Other | 8.5K | $1.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2019 | Snodgres Jon59 | Chief Financial Officer | Sell | 1,875 | $58.88 | $110,400.00 | -7.0% | |
| Feb 28, 2019 | Hunt Anthony75 | Chief Executive Officer | Sell | 7,475 | $59.01 | $441,099.75 | -3.0% | |
| Feb 28, 2019 | Kuriyel Ralf72 | Senior VP, R&D | Sell | 185 | $59.16 | $10,944.60 | -1.1% | |
| Dec 18, 2018 | Kuriyel Ralf72 | Senior VP, R&D | Sell | 311 | $54.44 | $16,930.84 | -2.5% | |
| Nov 26, 2018 | Snodgres Jon59 | CFO | Sale+OE | 31,753 | $63.49 | $2,015,915.41 | -60.3% | |
| Nov 5, 2018 | Ryan Thomas F Jr66 | Director | Sell | 1,763 | $65.75 | $115,920.42 | -35.3% | |
| Sep 10, 2018 | Hunt Anthony75 | Chief Executive Officer | Sale+OE | 27,566 | $57.71 | $1,590,809.05 | -10.8% | |
| Aug 29, 2018 | Barthelemy Nicolas67 | Director | Sale+OE | 6,580 | $54.44 | $358,196.12 | -61.1% | |
| Aug 28, 2018 | Snodgres Jon59 | CFO | Sell | 14,460 | $52.79 | $763,359.31 | -40.9% | |
| Aug 22, 2018 | Ryan Thomas F Jr66 | Director | Sell | 2,366 | $51.44 | $121,697.81 | -32.2% |